DK238588A - Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes - Google Patents

Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes

Info

Publication number
DK238588A
DK238588A DK238588A DK238588A DK238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A
Authority
DK
Denmark
Prior art keywords
trifluormethylphenoxy
phenylpropylamine
medicine
methyl
preparation
Prior art date
Application number
DK238588A
Other languages
Danish (da)
English (en)
Other versions
DK238588D0 (da
Inventor
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK238588D0 publication Critical patent/DK238588D0/da
Publication of DK238588A publication Critical patent/DK238588A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DK238588A 1987-05-04 1988-05-03 Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes DK238588A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4550987A 1987-05-04 1987-05-04

Publications (2)

Publication Number Publication Date
DK238588D0 DK238588D0 (da) 1988-05-03
DK238588A true DK238588A (da) 1988-11-05

Family

ID=21938301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK238588A DK238588A (da) 1987-05-04 1988-05-03 Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes

Country Status (11)

Country Link
EP (1) EP0294028B1 (ja)
JP (1) JP2721507B2 (ja)
KR (1) KR880013555A (ja)
AT (1) ATE93721T1 (ja)
AU (1) AU596296B2 (ja)
DE (1) DE3883606T2 (ja)
DK (1) DK238588A (ja)
ES (1) ES2058272T3 (ja)
HK (1) HK19595A (ja)
PH (1) PH23901A (ja)
ZA (1) ZA883115B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449562A3 (en) * 1990-03-29 1992-03-18 Eli Lilly And Company Use of r-fluoxetine as selective serotonin ic-receptor ligands
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
PT2316456T (pt) 2003-04-29 2017-09-05 Orexigen Therapeutics Inc Composições para afetar a perda de peso compreendendo naltrexona e bupropion
JP5180092B2 (ja) 2005-11-22 2013-04-10 オレキシジェン・セラピューティクス・インコーポレーテッド インスリン感受性を増すための組成物および方法
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
AU2007319472B2 (en) 2006-11-09 2013-01-17 Nalpropion Pharmaceuticals Llc Methods Of Administering Weight Loss Medications
CN101588795A (zh) 2006-11-09 2009-11-25 奥雷西根治疗公司 包含中间快速溶解层的分层药物制剂
MX2010012909A (es) 2008-05-30 2011-02-25 Orexigen Therapeutics Inc Metodos para tratamiento de condiciones de grasa visceral.
EP3659604A1 (en) 2010-01-11 2020-06-03 Nalpropion Pharmaceuticals, Inc. Methods of providing weight loss therapy in patients with major depression
HUE049859T2 (hu) 2012-06-06 2020-10-28 Nalpropion Pharmaceuticals Llc Készítmény magas kardiovaszkuláris kockázatnak kitett páciensekben túlsúly és elhízás kezelésére szolgáló eljárásban történõ alkalmazásra
WO2014021801A1 (en) 2012-07-31 2014-02-06 Sanovel Hayvan Sagligi Ürünleri Sanayi Ve Ticaret A.S. Use of fluoxetine in animals
EP2879517A1 (en) 2012-07-31 2015-06-10 Sanovel Hayvan Sagligi Ürünleri Sanayi ve Ticaret A.S. Use of fluoxetine for increasing meat and milk production
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
CA1267092A (en) * 1985-02-25 1990-03-27 Martin D. Hynes Analgesic composition containing codeine

Also Published As

Publication number Publication date
JPS63284126A (ja) 1988-11-21
ZA883115B (en) 1990-01-31
DE3883606D1 (de) 1993-10-07
AU596296B2 (en) 1990-04-26
JP2721507B2 (ja) 1998-03-04
AU1553388A (en) 1988-11-10
ES2058272T3 (es) 1994-11-01
EP0294028A3 (en) 1990-05-02
PH23901A (en) 1989-12-18
DK238588D0 (da) 1988-05-03
KR880013555A (ko) 1988-12-21
EP0294028A2 (en) 1988-12-07
DE3883606T2 (de) 1994-01-20
EP0294028B1 (en) 1993-09-01
ATE93721T1 (de) 1993-09-15
HK19595A (en) 1995-02-17

Similar Documents

Publication Publication Date Title
DK238588A (da) Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes
DK162965C (da) Anvendelse af et difluornucleosid eller et farmaceutisk acceptabelt salt deraf til fremstilling af et laegemiddel til behandling af neoplasma
FI883757A (fi) Terapeutiska nukleosider.
NO875022D0 (no) Apparat for medisinsk diagnostisering.
IT8104812A0 (it) Ago ipodermico.
EP0143977A3 (en) Bilobalid for use as a therapeutic substance
DE68912777D1 (de) Insulin-analoge.
DK159476C (da) Apparat til medicinsk behandling
DE3850471D1 (de) Automatischer Apparat zur heilenden Hydromassage.
NO872924D0 (no) Fibere inneholdende legemiddel for kontrollert frigjoering.
FI881651A0 (fi) Terapeutiska nukleosider.
DK49488D0 (da) Anaestesi-praeparat
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
DK369385A (da) Middel til behandling af schizofreni
IT8322773A0 (it) Perfezionamenti alle lenti all'infrarosso.
DK440288D0 (da) Middel til behandling af diabetes mellitus
DE3854179D1 (de) Vulkanisierbare Fluorkautschukzusammensetzung.
ES2019634B3 (es) Terapia con clorfeniramina.
DK591787A (da) Anvendelse af 5-(substitueret phenyl)-oxa-zolidinonderivater til fremstilling af et til behandling af depressioner egnet laegemiddel
FI881216A0 (fi) Terapeutiska nukleosider.
IT8719036A0 (it) Composizione terapeutica per complicazioni diabetiche.
KR890004654U (ko) 해밍용 프레스 금형의 구조
ES1004102Y (es) Dispositivo emisor-receptor poliedrico de efectos terapeuticos.
FI871295A0 (fi) Avlastningsanordning foer massavaror.
IT8121164V0 (it) Ago per anestesia dentaria intralegamentaria.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment